skip to content
Dovepress - Open Access to Scientific and Medical Research
View our mobile site

8129

Potentials and limitations of microorganisms as renal failure biotherapeutics

Review

(2404) Views  (679) Full article downloads

Authors: Poonam Jain, Sapna Shah, Razek Coussa, Satya Prakash

Published Date May 2009 Volume 2009:3 Pages 233 - 243
DOI: http://dx.doi.org/10.2147/BTT.S4964

Poonam Jain, Sapna Shah, Razek Coussa, Satya Prakash

Biomedical Technology and Cell Therapy Research Laboratory, Department of Biomedical Engineering and Physiology, Artificial Cells and Organs Research Centre, Faculty of Medicine, McGill University, Montreal, Québec, Canada

Abstract: Renal insufficiency leads to uremia, a complicated syndrome. It thus becomes vital to reduce waste metabolites and regulate water and electrolytes in kidney failure. The most common treatment of this disease is either dialysis or transplantation. Although these treatments are very effective, they are extremely costly. Recently artificial cells, microencapsulated live bacterial cells, and other cells have been studied to manage renal failure metabolic wastes. The procedure for microencapsulation of biologically active material is well documented and offers many biomedical applications. Microencapsulated bacteria have been documented to efficiently remove urea and several uremic markers such as ammonia, creatinine, uric acid, phosphate, potassium, magnesium, sodium, and chloride. These bacteria also have further potential as biotherapeutic agents because they can be engineered to remove selected unwanted waste. This application has enormous potential for removal of waste metabolites and electrolytes in renal failure as well as other diseases such as liver failure, phenylketonuria, and Crohn’s disease, to name a few. This paper discusses the various options available to date to manage renal failure metabolites and focuses on the potential of using encapsulated live cells as biotherapeutic agents to control renal failure waste metabolites and electrolytes.

Keywords: renal failure, microencapsulation, artificial cells, oral administration, bacterial cells, metabolites, electrolytes, polymeric membrane






 

Other articles by Professor Satya Prakash

A novel method for synthesizing PEGylated chitosan nanoparticles: strategy, preparation, and in vitro analysis
Angiopoietin-1-expressing adipose stem cells genetically modified with baculovirus nanocomplex: investigation in rat heart with acute infarction
Colon-targeted delivery of live bacterial cell biotherapeutics including microencapsulated live bacterial cells
Diet-induced metabolic hamster model of nonalcoholic fatty liver disease
Gut microbiota: next frontier in understanding human health and development of biotherapeutics
Human serum albumin nanoparticles as an efficient noscapine drug delivery system for potential use in breast cancer: preparation and in vitro analysis
Methods, potentials, and limitations of gene delivery to regenerate central nervous system cells
Mitotic and antiapoptotic effects of nanoparticles coencapsulating human VEGF and human angiopoietin-1 on vascular endothelial cells
  • Testimonials

    "... I was impressed at the rapidity of publication from submission to final acceptance." Dr Edwin Thrower, PhD, Yale University

  • Journal Indexing

    See where all the Dove Press journals are indexed